← Leaderboards
Nagi G Ayad
Scripps Florida
$6,400,285
Attributed
$8,836,631
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,836,631 · 6
By mechanism
R01$4,105,237 · 2
RM1$3,654,519 · 1
R21$693,125 · 2
R56$383,750 · 1
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsSmall MoleculeMalignant NeoplasmsPathway InteractionsCell CycleCell ProliferationCerebellumMedulloblastomaBrainNeuronsIn VivoIn VitroNovel TherapeuticsMouse ModelGranule CellPhosphotransferasesGene ExpressionKnockout MiceAffectNeuronal DifferentiationDefectInhibitor/AntagonistPhosphorylation
Grant awards (21)
Targeting Cell-Type Specific Disease Phenotypes to Promote CNS Repair$1,181,130
RM1 · FY2025 · NS
Rac1 Inhibition for the treatment of medulloblastoma$195,000
R21 · FY2025 · NS · contact PI
Targeting cell-type specific disease phenotypes to promote CNS repair$1,152,811
RM1 · FY2024 · NS
Epigenetic pathways and cell cycle exit$346,372
R01 · FY2024 · NS · contact PI
Rac1 Inhibition for the treatment of medulloblastoma$234,000
R21 · FY2024 · NS · contact PI
Targeting cell-type specific disease phenotypes to promote CNS repair$1,320,578
RM1 · FY2023 · NS
Epigenetic pathways and cell cycle exit$357,086
R01 · FY2023 · NS · contact PI
Epigenetic pathways and cell cycle exit$357,086
R01 · FY2022 · NS · contact PI
Epigenetic pathways and cell cycle exit$360,724
R01 · FY2021 · NS · contact PI
Epigenetic pathways and cell cycle exit$1
R01 · FY2021 · NS · contact PI
Epigenetic pathways and cell cycle exit$360,725
R01 · FY2020 · NS · contact PI
Epigenetic and Kinase Pathway Interactions in Medulloblastoma$383,750
R56 · FY2017 · NS · contact PI
The Anaphase Promoting Complex and Cell Cycle Exit$425,432
R01 · FY2014 · NS · contact PI
The Anaphase Promoting Complex and Cell Cycle Exit$424,184
R01 · FY2013 · NS · contact PI
The Anaphase Promoting Complex and Cell Cycle Exit$449,730
R01 · FY2012 · NS · contact PI
The Anaphase Promoting Complex and Cell Cycle Exit$460,221
R01 · FY2011 · NS · contact PI
The Anaphase Promoting Complex and Cell Cycle Exit$541,896
R01 · FY2010 · NS · contact PI
The Anaphase Promoting Complex and Cell Cycle Exit$21,780
R01 · FY2010 · NS · contact PI
Small-molecule Inhibitors of Wee1 Degradation and Mitotic Entry$47,725
R21 · FY2008 · NS · contact PI
Small-molecule Inhibitors of Wee1 Degradation and Mitotic Entry$43,275
R21 · FY2007 · NS · contact PI
Small-molecule Inhibitors of Wee1 Degradation and Mitotic Entry$173,125
R21 · FY2006 · NS · contact PI